Pharmadrug (PHRX) Stock Statistics & Valuation Metrics

Pharmadrug has a market cap or net worth of C$671.07K. The enterprise value is C$2.64M.

Pharmadrug has 134,214,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmadrug’s return on equity (ROE) is 0.57 and return on invested capital (ROIC) is -639.06%.

The current PE Ratio of Pharmadrug is ―. Pharmadrug’s PEG ratio is 0.01.

In the last 12 months, Pharmadrug had revenue of 0.00 and earned -793.27K in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -136.83K and capital expenditures 0.00, giving a free cash flow of -136.83K billion.

Pharmadrug pays an annual dividend of ―, resulting in a dividend yield of ―

Pharmadrug upcoming earnings date is Aug 21, 2026, TBA (Confirmed).

Pharmadrug as a current ratio of 0.08, with Debt / Equity ratio of -103.19%

In the past 12 months, Pharmadrug has paid 0.00 in taxes.

Pharmadrug EV to EBITDA ratio is -4.21, with an EV/FCF ratio of -3.01.

Pharmadrug has C$387.71K in cash and marketable securities with C$1.61M in debt, giving a net cash position of -C$1.22M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Pharmadrug is ―, which is 11.43% higher than the current price. The consensus rating is ―